Balch, C. M., Soong, S. J., Atkins, M. B., Buzaid, A. C., Cascinelli, N., Coit, D. G., ... Thompson, J. F. (2004). An evidence-based staging system for cutaneous melanoma. CA: a cancer journal for clinicians, 54(3), 131-49; quiz 182-4.

Bastiaannet, E., Wobbes, T., Hoekstra, O. S., van der Jagt, E. J., Brouwers, A. H., Koelemij, R., ... Hoekstra, H. J. (2009). Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment. Journal of clinical oncology, 27(28), 4774-80.

Bochev, P., Klisarova, A., Kaprelyan, A., Chaushev, B., & Dancheva, Z. (2012). Brain metastases detectability of routine whole body (18)F-FDG PET and low dose CT scanning in 2502 asymptomatic patients with solid extracranial tumors. Hellenic journal of nuclear medicine, 15(2), 125-9.

Brierley, J. D., Gospodarowicz, M. K., & Wittekind, C. (2017). TNM classification of malignant tumours. Wiley-Blackwell.

Chai, C. Y., Zager, J. S., Szabunio, M. M., Marzban, S. S., Chau, A., Rossi, R. M., & Sondak, V. K. (2012). Preoperative ultrasound is not useful for identifying nodal metastasis in melanoma patients undergoing sentinel node biopsy: preoperative ultrasound in clinically node-negative melanoma. Annals of surgical oncology, 19(4), 1100-6.

Coit, D. G., Thompson, J. A., Albertini, M. R., Barker, C., Carson, W. E., Contreras, C., ... Engh, A. M. (2019). Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 17(4), 367-402.

Edge, S., Byrd, S. R., ... Trotti, A. (2010). AJCC Cancer Staging Manual. Springer-Verlag.

Gershenwald, J. E., & Scolyer, R. A. (2018). Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond. Annals of surgical oncology, 25(8), 2105-2110.

Gold, J. S., Jaques, D. P., Busam, K. J., Brady, M. S., & Coit, D. G. (2007). Yield and predictors of radiologic studies for identifying distant metastases in melanoma patients with a positive sentinel lymph node biopsy. Annals of surgical oncology, 14(7), 2133-40.

Goyal, S., Silk, A. W., Tian, S., Mehnert, J., Danish, S., Ranjan, S., & Kaufman, H. L. (2015). Clinical Management of Multiple Melanoma Brain Metastases: A Systematic Review. JAMA oncology, 1(5), 668-76.

Holtkamp, L. H. J., Read, R. L., Emmett, L., Thompson, J. F., & Nieweg, O. E. (2017). Futility of imaging to stage melanoma patients with a positive sentinel lymph node. Melanoma research, 27(5), 457-462.

Kesson, E. M., Allardice, G. M., George, W. D., Burns, H. J., & Morrison, D. S. (2012). Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ (Clinical research ed.), 344, e2718.

Keung, E. Z., & Gershenwald, J. E. (2018). The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care. Expert review of anticancer therapy, 18(8), 775-784.

Nasjonalt kvalitetsregister for melanom (2021). Årsrapport 2020: resultater og forbedringstiltak fra Nasjonalt kvalitetsregister for melanom. Oslo: Kreftregisteret. Hentet fra https://www.kvalitetsregistre.no/sites/default/files/2021-10/%C3%85rsrapport%20Nasjonalt%20kvalitetsregister%20for%20melanom%202020.pdf

Rodriguez Rivera, A. M., Alabbas, H., Ramjaun, A., & Meguerditchian, A. N. (2014). Value of positron emission tomography scan in stage III cutaneous melanoma: a systematic review and meta-analysis. Surgical oncology, 23(1), 11-6.

Romano, E., Scordo, M., Dusza, S. W., Coit, D. G., & Chapman, P. B. (2010). Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines. Journal of clinical oncology, 28(18), 3042-7.

Sainsbury, R., Haward, B., Rider, L., Johnston, C., & Round, C. (1995). Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet, 345(8960), 1265-70.

Schroer-Gunther, M. A., Wolff, R. F., Westwood, M. E., Scheibler, F. J., Schurmann, C., Baumert, B. G., ... Kleijnen, J. (2012). F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review. Systematic reviews, 1, 62.

Schule, S. C., Eigentler, T. K., Garbe, C., la Fougere, C., Nikolaou, K., & Pfannenberg, C. (2016). Influence of (18)F-FDG PET/CT on therapy management in patients with stage III/IV malignant melanoma. European journal of nuclear medicine and molecular imaging, 43(3), 482-8.

Xing, Y., Bronstein, Y., Ross, M. I., Askew, R. L., Lee, J. E., Gershenwald, J. E., ... Cormier, J. N. (2011). Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. Journal of the National Cancer Institute, 103(2), 129-42.